COVID-19

“Ultra-potent” antibody against COVID-19 variants isolated at VUMC

A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant.

Older age, chronic co-morbidities associated with more severe COVID disease in children

Vanderbilt research found that multiple factors are associated with the severity of COVID-19 disease in children, including older age and chronic co-morbidities such as obesity, diabetes and neurologic conditions.

Michael Harris works with Katherine Gilliland, FNP, during the recent transition of clinical and IT systems at Vanderbilt Tullahoma-Harton Hospital.

IT transition a success at Vanderbilt Tullahoma-Harton Hospital

Multiple teams from across Vanderbilt University Medical Center recently led a transition of the clinical and information technology (IT) systems at Vanderbilt Tullahoma-Harton Hospital.

Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients

Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.

A leading authority in ICU-related depression and PTSD, Jim Jackson’s skills have proven especially critical to helping patients during the pandemic

“The last year has been so traumatizing and hard, but to use the skills and knowledge that we have been developing to good effect in the service of others during this difficult season has been meaningful.”

Alarming number of pregnant COVID-19 patients hospitalized in August

Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).

1 9 10 11 12 13 39